Publications by authors named "Samah Alimam"

Claim this Profile
A
Adolescent and young adult patients with 'Philadelphia negative' myeloproliferative neoplasms: a real world, UK tertiary-centre study.
Dipal Mehta, Holly Theaker, Hugo Ferreira, Syeda Ahmed, Aisha Roble, Samah Alimam

Curr Res Transl Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular risk in a contemporary cohort of patients with myeloproliferative neoplasms'.
Dipal Mehta, Samah Alimam, Donal P McLornan, John A Henry, Syeda Ahmed

Curr Res Transl Med· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine learning in transfusion medicine: A scoping review.
Suzanne Maynard, Joseph Farrington, Samah Alimam, Hayley Evans, Kezhi Li

Transfusion· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myeloproliferative neoplasms in adolescents and young adults.
Rodothea Amerikanou, Jonathan Lambert, Samah Alimam

Best Pract Res Clin Haematol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Altered immune response to the annual influenza A vaccine in patients with myeloproliferative neoplasms.
Samah Alimam, Jessica Ann Timms, Claire N Harrison, Richard Dillon, Tracey Mare

Br J Haematol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients with triple-negative, JAK2V617F- and CALR-mutated essential thrombocythemia share a unique gene expression signature.
Samah Alimam, William Villiers, Richard Dillon, Michael Simpson, Manohursingh Runglall

Blood Adv· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular MRD status and outcome after transplantation in NPM1-mutated AML.
Richard Dillon, Robert Hills, Sylvie Freeman, Nicola Potter, Jelena Jovanovic, Samah Alimam

Blood· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The poor outcome in high molecular risk, hydroxycarbamide-resistant/intolerant ET is not ameliorated by ruxolitinib.
Jennifer M O'Sullivan, Angela Hamblin, Christina Yap, Sonia Fox, Rebecca Boucher, Samah Alimam

Blood· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Essential thrombocythaemia treated with recombinant interferon: 'real world' United Kingdom referral centre experience.
Joana Desterro, Donal P McLornan, Natalia Curto Garcia, Jennifer O'Sullivan, Samah Alimam

Br J Haematol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shortened telomeres in essential thrombocythemia: clinicopathological and treatment correlations.
Samah Alimam, Donal P McLornan, Jie Jiang, Deepti Radia, Ghulam J Mufti

Haematologica· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ruxolitinib vs best available therapy for ET intolerant or resistant to hydroxycarbamide.
Claire N Harrison, Adam J Mead, Anesh Panchal, Sonia Fox, Christina Yap, Samah Alimam

Blood· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experience with ruxolitinib in the treatment of polycythaemia vera.
Samah Alimam, Claire Harrison

Ther Adv Hematol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of venous thromboembolism in pregnant women with essential thrombocythemia: a systematic review and meta-analysis.
Leslie Skeith, Marc Carrier, Susan E Robinson, Samah Alimam, Marc A Rodger

Blood· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease characteristics and outcomes in younger adults with primary and secondary myelofibrosis.
Yan Beauverd, Samah Alimam, Donal P McLornan, Deepti H Radia, Claire N Harrison

Br J Haematol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pregnancy outcomes in myeloproliferative neoplasms: UK prospective cohort study.
Samah Alimam, Susan Bewley, Lucy C Chappell, Marian Knight, Paul Seed

Br J Haematol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiplatelet therapy versus observation in low-risk essential thrombocythemia with a CALR mutation.
Alberto Alvarez-Larrán, Arturo Pereira, Paola Guglielmelli, Juan Carlos Hernández-Boluda, Eduardo Arellano-Rodrigo, Alimam Samah

Haematologica· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How we diagnose and treat essential thrombocythaemia.
Samah Alimam, Bridget S Wilkins, Claire N Harrison

Br J Haematol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of JAK inhibitors for low-risk myelofibrosis.
Samah Alimam, Donal McLornan, Claire Harrison

Expert Rev Hematol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sudden onset bilateral deafness as a presentation of chronic myeloid leukaemia.
Samah M Alimam, Mohd K Mamat, Samar Kulkarni, Tim C P Somervaille

Br J Haematol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis